The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

The Cambridge-based company says the vaccine is at least as good as getting both vaccines separately, it will seek FDA ...

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

While sales of its COVID-19 vaccine continue to decline as expected in a post-pandemic market, Moderna is taking proactive steps to reshape its future. The company is swiftly advancing multiple ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

The Trump administration stopped the study. Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against ...

Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.